City

Marathi | Hindi

Epaper
AllNewsPhotos

Cipla

Cipla-limited, Latest Marathi News

Read more

Cipla Limited is an Indian multinational pharmaceutical and biotechnology company, headquartered in Mumbai, India. Cipla primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes, weight control and depression; other medical conditions.

National : COVID-19: Production capacity of Remdesivir increased to nearly 119 lakh vials per month, says Govt

Business : Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability of baricitinib for Covid-19 patients

Business : Pharmaceutical market rebounds in March at 10.3 pc: Ind-Ra

National : Indore faces shortage of Remdesivir, oxygen supplies

Business : Equity indices erase early gains, banking stocks suffer

Business : Equity in green amid volatile session, SBI up 11 pc

Business : Equity indices trade lower, IT scrips under pressure

International : COVID-19: 3 Indian companies start supply of life-saving Remdesivir to Nepal

Health : Cipla gets DGCI nod to sell Favipiravir under brand 'Ciplenza'

Business : Cipla gets regulatory nod for launch of Ciplenza to treat mild to moderate Covid-19